Variant on chromosome 9p is associated with left ventricular mass: results from two cohorts of essential

Cristina Menni1, Lucia Boffi, Francesca Cesana

  • 1Department of Clinical Medicine and Prevention, San Gerardo Hospital, University of Milano-Bicocca, Milan, Italy.

Journal of Hypertension
|September 4, 2012
PubMed

Insights

A newly identified genetic variant (rs894379) in the CNTLN gene on chromosome 9p22 is associated with increased left ventricular mass (LVM) in hypertensive patients. This finding may enhance understanding of genetic factors influencing LVM progression.

Area of Science:

  • Cardiovascular Genetics
  • Hypertension Research
  • Molecular Cardiology

Background:

  • Increased left ventricular mass (LVM) in hypertensive patients predicts cardiovascular events.
  • Mechanisms of LVM progression in hypertension are not fully understood.
  • The 9p21 chromosomal region is linked to coronary heart disease.

Purpose of the Study:

  • To investigate the association between genetic variants in chromosome 9 and LVM in hypertensive individuals.
  • To identify specific single nucleotide polymorphisms (SNPs) influencing LVM.
  • To explore the genetic determinants of LVM in hypertension.

Main Methods:

  • Genomic analysis of 384 SNPs in chromosome 9 in 821 hypertensive individuals.
  • Identification and validation of a significant SNP (rs894379) in the CNTLN gene.
  • Follow-up validation in an independent cohort of 1038 hypertensive individuals.

Main Results:

  • A specific SNP, rs894379, located in the CNTLN gene on chromosome 9p22, was associated with increased LVM.
  • The minor allele G of rs894379 showed a significant association with higher LVM.
  • Combined analysis confirmed a nominal association for rs894379 (β = 2.46, P = 0.0026).

Conclusions:

  • A novel genetic variant associated with echocardiography-measured LVM has been identified.
  • This finding contributes to understanding the genetic basis of LVM in hypertension.
  • Further investigation is warranted to elucidate the role of this variant in cardiovascular outcomes.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...